|
GCA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.95349996973727E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.5719000001635E-07 |
| Normal-vs-Stage2 |
2.42120001825441E-09 |
| Normal-vs-Stage3 |
2.29479999999116E-05 |
| Normal-vs-Stage4 |
4.92980000155185E-08 |
| Stage1-vs-Stage2 |
1.188230E-02 |
| Stage1-vs-Stage3 |
7.345400E-01 |
| Stage1-vs-Stage4 |
6.318200E-02 |
| Stage2-vs-Stage3 |
1.205540E-02 |
| Stage2-vs-Stage4 |
5.556000E-01 |
| Stage3-vs-Stage4 |
5.618100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.3628999995241E-07 |
| Normal-vs-AfricanAmerican |
1.958190E-01 |
| Normal-vs-Asian |
1.331600000265E-07 |
| Caucasian-vs-AfricanAmerican |
1.518370E-01 |
| Caucasian-vs-Asian |
1.473630E-01 |
| AfricanAmerican-vs-Asian |
5.473700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.13160000001245E-06 |
| Normal-vs-Female |
5.84229997713237E-09 |
| Male-vs-Female |
5.708000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.38209999959116E-07 |
| Normal-vs-Age(41-60Yrs) |
1.60389999948052E-07 |
| Normal-vs-Age(61-80Yrs) |
2.64540000016744E-07 |
| Normal-vs-Age(81-100Yrs) |
9.945200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.813400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.803400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.568400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.868200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.279900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.854300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.039600E-02 |
| Classical-VS-Follicular |
2.300000E-03 |
| Classical-VS-Other |
3.122000E-01 |
| Classical-VS-Normal |
3.58550000001401E-06 |
| Tall-VS-Follicular |
1.721440E-03 |
| Tall-VS-Other |
1.345220E-01 |
| Tall-VS-Normal |
2.237400E-01 |
| Follicular-VS-Other |
9.833400E-01 |
| Follicular-VS-Normal |
1.96089999793259E-09 |
| Other-VS-Normal |
7.642000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.35209998752828E-09 |
| Normal-vs-N1 |
1.213000000444E-08 |
| N0-vs-N1 |
4.523400E-01 |
|
|
